Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05429736 · ClinicalTrials.gov registry record · NA
Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity
A NA study of Spasticity, Muscle and Incomplete Spinal Cord Injury, sponsored by Shepherd Center, Atlanta GA.
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05429736: Recruiting NA study of Spasticity, Muscle and Incomplete Spinal Cord Injury, sponsored by Shepherd Center, Atlanta GA.
NCT05429736 is a NA study of Spasticity, Muscle and Incomplete Spinal Cord Injury that is actively recruiting participants, run by Shepherd Center, Atlanta GA. The registered enrollment target is 28 participants, below the 77-participant average among 11 other Spasticity, Muscle trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05429736, a NA study of Spasticity, Muscle and Incomplete Spinal Cord Injury, is actively recruiting participants, sponsored by Shepherd Center, Atlanta GA.
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
For many people with spinal cord injury (SCI), the goal of walking is a high priority. There are many approaches available to restore walking function after SCI; however, these approaches often involve extensive rehabilitation training and access to facilities, qualified staff, and advanced technology that make practicing walking at home difficult. For this reason, developing training approaches that could be easily performed in the home would be of great value. In addition, non-invasive spinal stimulation has the potential to increase the effectiveness of communication between the brain and spinal cord. Combining motor skill training (MST) with transcutaneous spinal stimulation (TSS) may further enhance the restoration of function in persons with SCI. Therefore, the purpose of this study is to determine if moderate-intensity, MST can improve walking-related outcomes among persons with SCI and to determine if the addition of non-invasive TSS will result in greater improvements in function compared to training alone.
Primary Outcome
Walking speed (as determined by the 10MWT) is the primary outcome measure for assessing walking function. Participants will complete 3 10MWT trials at each testing session, separated by 2 minutes of seated rest. The average walking speed of the 3 walks will be calculated and used in the analyses.
Conditions Studied
Interventions
- BEHAVIORAL Motor Skill Training (MST)
- DEVICE Transcutaneous Spinal Stimulation (TSS)
Study Locations (1)
Georgia
- Shepherd Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05429736 shows while recruiting
NCT05429736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 77-participant average among 11 other Spasticity, Muscle trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Spasticity, Muscle appearing as the primary indexed condition, and to 2 interventions - of which Motor Skill Training (MST) is the first listed.
NCT05429736 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05429736 about?
NCT05429736 is a clinical study titled "Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity". For many people with spinal cord injury (SCI), the goal of walking is a high priority. There are many approaches available to restore walking function after SCI; however, these approaches often involve extensive rehabilitation training and access to facilities, qualified staff, and advanced technolo...
What is the current status of trial NCT05429736?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2022-03-01. Estimated completion is 2026-03.
What conditions does trial NCT05429736 study?
This clinical trial studies the following conditions: Spasticity, Muscle, Incomplete Spinal Cord Injury.
What interventions are being tested in trial NCT05429736?
The interventions under investigation include: Motor Skill Training (MST) (BEHAVIORAL), Transcutaneous Spinal Stimulation (TSS) (DEVICE).
Who is sponsoring clinical trial NCT05429736?
This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05429736 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasticity, Muscle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05429736's enrollment target sits among peer trials
28 7th of 11 higher than 5 of 11 other Spasticity, Muscle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spasticity, Muscle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning
RECRUITING · NA
-
Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury
RECRUITING · NA
-
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
RECRUITING · NA
-
DDN in Stroke--COBRE
COMPLETED · NA
-
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI